Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Maria Luisa Gomez-Dorronsoro"'
Autor:
Leyre Pérez-Ricarte, Marta Benavent, A. Viudez, Maria Del Carmen Riesco, Paula Jiménez-Fonseca, Juan Jesús Marín-Méndez, Iranzu González-Borja, Marta Llanos, Saioa Goñi, Jaume Capdevila, Beatriz García-Paredes, Vicente Alonso, Ana Custodio, Maika Durantez, J. Hernando, Rocio Garcia-Carbonero, Imanol Arozarena, Isabel Sevilla, Ana De Jesus Acosta, Irene Hernández-García, Guillermo Crespo, Alberto Carmona-Bayonas, Jairo Pérez-Sanz, Maria Luisa Gomez Dorronsoro, Ruth Vera, Borja Lopez De San Vicente, Carlos F. Lopez
Publikováno v:
Pancreatology. 21:215-223
Background Pancreatic neuroendocrine tumors are rare neoplasms for which few predictive and/or prognostic biomarkers have been validated. Our previous work suggested the potential of the combined expression of N-myc downstream-regulated gen-1 (NDRG-1
Autor:
Maria Luisa Gomez-Dorronsoro, Berta Ibáñez-Beroiz, Ruth Vera, María del Rosario Mercado, Pablo Azcue, Ignacio Encío, David Guerrero Setas
Publikováno v:
Cancers; Volume 13; Issue 23; Pages: 5909
Cancers
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Cancers, Vol 13, Iss 5909, p 5909 (2021)
Cancers
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Cancers, Vol 13, Iss 5909, p 5909 (2021)
Simple Summary Decision about treatment choice in early-stage colon cancer may be difficult for clinicians because of a lack of published data. Colon cancer is a very heterogeneous disease, but some previous efforts have helped us elucidate potential
Autor:
Ruth Vera, María del Rosario Mercado, Javier Suarez Alecha, Maria Luisa Gomez-Dorronsoro, Pablo Azcue, David Guerrero Setas, Arkaitz Galbete, Ignacio Encío
Publikováno v:
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
instname
Cancers, Vol 13, Iss 1943, p 1943 (2021)
Cancers
Volume 13
Issue 8
instname
Cancers, Vol 13, Iss 1943, p 1943 (2021)
Cancers
Volume 13
Issue 8
Background. There is a patent need to better characterize early-stage colorectal cancer (CRC) patients. PD-1 ligand (PD-L1) expression has been proposed as a prognostic factor but yields mixed results in different settings. The Consensus Molecular Su
Autor:
J. Hernando, B. García Paredes, L. Lopez Ricarte, Alberto Carmona, I. Sevilla García, Inés González, B. López-San Vicente, M. Benavent, P. Jiménez-Fonseca, Saioa Goñi, J. Pérez Sanz, Maria Luisa Gomez-Dorronsoro, Jose J.G. Marin, Irene Hernandez, A. De Jesus-Acosta, Ana Custodio, Vicente Alonso-Orduña, Gustavo Crespo, A. Viudez, C. López
Publikováno v:
Annals of Oncology. 31:S775
Autor:
M. Benavent, Guillermo Crespo, Antonio Viudez, Jairo Pérez-Sanz, Alberto Carmona, Saioa Goñi, Maria Luisa Gomez-Dorronsoro, Carlos F. Lopez, Marta Llanos, Vicente Alonso, J. Hernando, Isabel Sevilla, Iranzu González-Borja, Ana De Jesus-Acosta, Irene Hernandez, Borja Lopez De San Vicente, Beatriz Roig García, Ana Custodio
Publikováno v:
Journal of Clinical Oncology. 38:e16707-e16707
e16707 Background: Previously our group showed the potential use of a score based (SPI) on MGMT, NDRG-1 and PHLDA-3 immunohistochemistry (IHC) expression as predictor of outcome in operated PanNET (Viúdez et al. Oncotarget 2016). The present retrosp
Autor:
Jordi Rubió-Casadevall, Miguel Taron, Julia Cruz, Teresa Serrano, Luis Vicioso, Antonio Gutierrez, Antonio Fernandez-Serra, Nuria Lainez, Javier Martin-Broto, Rosa Ortiz-Duran, Maria Lopez-Alvarez, Javier Martinez-Trufero, Ramiro Alvarez-Alegret, José Antonio López-Guerrero, Isabel Sevilla, Nadia Hindi, César Serrano, David S. Moura, Xavier Garcia del Muro, Rafael Ramos, Maria Luisa Gomez-Dorronsoro
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Oncotarget
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Biblos-e Archivo. Repositorio Institucional de la UAM
Digital.CSIC. Repositorio Institucional del CSIC
Universidad de Barcelona
Oncotarget
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Biblos-e Archivo. Repositorio Institucional de la UAM
Digital.CSIC. Repositorio Institucional del CSIC
[Introduction] There are limited findings available on KIT-negative GIST-like (KNGL) population. Also, KIT expression may be post-transcriptionally regulated by miRNA221 and miRNA222. Hence, the aim of this study is to characterize KNGL population, b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb28de91e70eca5046f358fd09338255
http://hdl.handle.net/2445/178609
http://hdl.handle.net/2445/178609
Autor:
Imanol Arozarena, Maria Luisa Gomez-Dorronsoro, Saioa Goñi, M. Benavent, A. De Jesus-Acosta, V. Alonso, G. Crespo Herrero, V. Arrazubi Arrula, Marta Llanos, Ana Custodio, Marina Baretti, Iranzu González-Borja, B. López de San Vicente, C. López, R. Grandez, M.C. Riesco Martínez, A. Viudez, A. Carmona Bayonas, P. Jiménez-Fonseca
Publikováno v:
Annals of Oncology. 30:v196
Background Previously our group showed the potential use of a score based on MGMT, NDRG-1 and PHLDA-3 immunohistochemistry (IHC) expression as predictor of outcome in operated PanNET. The present multicenter project is retrospectively analyzing the p
Autor:
Virginia Martínez-Marín, Mónica Jorge Fernández, J. M. Campos, Adelaida La Casta Munoa, Clara Montagut Viladot, Ana Belén Muñoz Ruiz, Jose Maria Vieitez de Prado, Miguel Marin, E. Falcó, Ruth Vera, Juan Ramón Ayuso, Joan Figueras, Maria Luisa Gomez Dorronsoro, Pilar Alfonso, Maria Jose Safont, Juan Carlos Cámara, Mercedes Salgado Fernández, Jorge Aparicio, Marta Martin-Richard, Carles Pericay
Publikováno v:
Journal of Clinical Oncology. 33:e14656-e14656
e14656 Background: The RECIST criteria may be limited in assessing response to biologic agents such as bevacizumab (BVZ). Retrospective studies of patients (pts) with colorectal liver metastases (C...
Autor:
Javier Suárez, Ruth Vera, Marta Montes, D. Guerrero, Angela Fernandez de Lascoiti, José Antonio Rivadeneira Cabana, Maria Luisa Gomez Dorronsoro, Miguel Angel Ciga Lozano, Irene Hernandez, Antonio Tarifa, Antonio Viudez, Juan Verdun
Publikováno v:
Annals of Oncology. 24:iv117
e14589 Background: Tejpar et al (JCO2012; 30(29):3570-7) showed that patients with aCRC and Gly13D kras mutation experienced worse response rate with chemotherapy alone compared to those with other kras mutations. This retrospective study analyzes di
Autor:
Marta Montes, Natalia Torrea, Victor Chicata, Francisco Monzon, Fernando Arias, Pedro Armendariz, E. Balen, D. Guerrero, Eva Bandrés, Irene Hernandez, Gemma Asin, Marisol Gonzalez-Huarriz, Inés López, C. Eito, Antonio Viudez, Jesús García-Foncillas, Maria Luisa Gomez Dorronsoro
Publikováno v:
Journal of Clinical Oncology. 30:e14057-e14057
e14057 Background: MicroRNAs (miRNA), small non-coding RNA molecules act as post-transcriptional regulators of gene expression and have shown diagnostic and prognostic potential in cancer. We profiled miRNA expression in LARC patients treated with ne